 Administration, Cutaneous
"Administration, Cutaneous" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The application of suitable drug dosage forms to the skin for either local or systemic effects.
| Descriptor ID |
D000279
|
| MeSH Number(s) |
E02.319.267.120.060
|
| Concept/Terms |
Administration, Cutaneous- Administration, Cutaneous
- Administration, Dermal
- Administrations, Dermal
- Dermal Administrations
- Dermal Administration
- Cutaneous Administration
- Administrations, Cutaneous
- Cutaneous Administrations
- Skin Administration, Drug
- Drug Skin Administrations
- Skin Administrations, Drug
- Drug Administration, Cutaneous
- Administration, Cutaneous Drug
- Administrations, Cutaneous Drug
- Cutaneous Drug Administrations
- Drug Administrations, Cutaneous
- Cutaneous Drug Administration
- Dermal Drug Administration
- Administration, Dermal Drug
- Administrations, Dermal Drug
- Dermal Drug Administrations
- Drug Administrations, Dermal
- Drug Administration, Dermal
- Skin Drug Administration
- Skin Drug Administrations
- Cutaneous Administration, Drug
- Cutaneous Administrations, Drug
Administration, Transcutaneous- Administration, Transcutaneous
- Administrations, Transcutaneous
- Transcutaneous Administrations
- Administration, Transdermal
- Administrations, Transdermal
- Transdermal Administrations
- Transdermal Administration
- Transcutaneous Administration
Percutaneous Administration- Percutaneous Administration
- Administration, Percutaneous
- Administrations, Percutaneous
- Percutaneous Administrations
|
Below are MeSH descriptors whose meaning is more general than "Administration, Cutaneous".
Below are MeSH descriptors whose meaning is more specific than "Administration, Cutaneous".
This graph shows the total number of publications written about "Administration, Cutaneous" by people in UAMS Profiles by year, and whether "Administration, Cutaneous" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2023 | 0 | 1 | 1 | | 2020 | 0 | 3 | 3 | | 2019 | 0 | 1 | 1 | | 2017 | 0 | 4 | 4 | | 2016 | 0 | 2 | 2 | | 2015 | 0 | 1 | 1 | | 2014 | 0 | 4 | 4 | | 2013 | 0 | 2 | 2 | | 2012 | 0 | 1 | 1 | | 2010 | 0 | 4 | 4 | | 2009 | 0 | 3 | 3 | | 2008 | 1 | 2 | 3 | | 2006 | 0 | 2 | 2 | | 2005 | 0 | 8 | 8 | | 2004 | 0 | 2 | 2 | | 2003 | 0 | 1 | 1 | | 2001 | 0 | 2 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Administration, Cutaneous" by people in Profiles over the past ten years.
-
Greenhawt M, Sindher SB, Wang J, O'Sullivan M, du Toit G, Kim EH, Albright D, Anvari S, Arends N, Arkwright PD, B?gin P, Blumchen K, Bourrier T, Brown-Whitehorn T, Cassell H, Chan ES, Ciaccio CE, Deschildre A, Divaret-Chauveau A, Dorris SL, Dorsey MJ, Eiwegger T, Erlewyn-Lajeunesse M, Fleischer DM, Ford LS, Garcia-Lloret M, Giovannini-Chami L, Hourihane JO, Jay N, Jones SM, Kerns LA, Kloepfer KM, Leonard S, Lezmi G, Lieberman JA, Lomas J, Makhija M, Parrish C, Peake J, Perrett KP, Petroni D, Pf?tzner W, Pongracic JA, Quinn P, Robison RG, Sanders G, Schneider L, Sharma HP, Trujillo J, Turner PJ, Tuttle K, Upton JE, Varshney P, Vickery BP, Vogelberg C, Wainstein B, Wood RA, Bee KJ, Campbell DE, Green TD, Rouissi R, Peillon A, Bahnson HT, Bois T, Sampson HA, Burks AW. Phase 3 Trial of Epicutaneous Immunotherapy in Toddlers with Peanut Allergy. N Engl J Med. 2023 May 11; 388(19):1755-1766.
-
Costantino RC, Gressler LE, Onukwugha E, McPherson ML, Fudin J, Villalonga-Olives E, Slejko JF. Initiation of Transdermal Fentanyl Among US Commercially Insured Patients Between 2007 and 2015. Pain Med. 2020 10 01; 21(10):2229-2236.
-
Paul B, Hamadeh I, Atrash S, Bhutani M, Voorhees P, Usmani SZ. Daratumumab subcutaneous formulation for the treatment of multiple myeloma. Expert Opin Biol Ther. 2020 11; 20(11):1253-1259.
-
Madsen S, Price KN, Shi VY, Lio PA. Pearls in Mitigating Application Pain of Topical Nonsteroidal Agents. Dermatology. 2020; 236(5):477-480.
-
Fleischer DM, Shreffler WG, Campbell DE, Green TD, Anvari S, Assa'ad A, B?gin P, Beyer K, Bird JA, Brown-Whitehorn T, Byrne A, Chan ES, Cheema A, Chinthrajah S, Chong HJ, Davis CM, Ford LS, Gagnon R, Greenhawt M, Hourihane JO, Jones SM, Kim EH, Lange L, Lanser BJ, Leonard S, Mahler V, Maronna A, Nowak-Wegrzyn A, Oriel RC, O'Sullivan M, Petroni D, Pongracic JA, Prescott SL, Schneider LC, Smith P, Staab D, Sussman G, Wood R, Yang WH, Lambert R, Peillon A, Bois T, Sampson HA. Long-term, open-label extension study of the efficacy and safety of epicutaneous immunotherapy for peanut allergy in children: PEOPLE 3-year results. J Allergy Clin Immunol. 2020 10; 146(4):863-874.
-
Jaros J, Hendricks AJ, Shi VY, Lio PA. A Practical Approach to Recalcitrant Face and Neck Dermatitis in Atopic Dermatitis. Dermatitis. 2020 May-Jun; 31(3):169-177.
-
Hendricks AJ, Lio PA, Shi VY. Management Recommendations for Dupilumab Partial and Non-durable Responders in Atopic Dermatitis. Am J Clin Dermatol. 2019 Aug; 20(4):565-569.
-
Lee GR, Maarouf M, Hendricks AJ, Lee DE, Shi VY. Topical probiotics: the unknowns behind their rising popularity. Dermatol Online J. 2019 May 15; 25(5).
-
Maarouf M, Hendricks AJ, Shi VY. Bathing Additives for Atopic Dermatitis - A Systematic Review. Dermatitis. 2019 May/Jun; 30(3):191-197.
-
Fleischer DM, Greenhawt M, Sussman G, B?gin P, Nowak-Wegrzyn A, Petroni D, Beyer K, Brown-Whitehorn T, Hebert J, Hourihane JO, Campbell DE, Leonard S, Chinthrajah RS, Pongracic JA, Jones SM, Lange L, Chong H, Green TD, Wood R, Cheema A, Prescott SL, Smith P, Yang W, Chan ES, Byrne A, Assa'ad A, Bird JA, Kim EH, Schneider L, Davis CM, Lanser BJ, Lambert R, Shreffler W. Effect of Epicutaneous Immunotherapy vs Placebo on Reaction to Peanut Protein Ingestion Among Children With Peanut Allergy: The PEPITES Randomized Clinical Trial. JAMA. 2019 03 12; 321(10):946-955.
-
Lee GR, Maarouf M, Hendricks AK, Lee DE, Shi VY. Current and emerging therapies for hand eczema. Dermatol Ther. 2019 05; 32(3):e12840.
-
Vaughn AR, Clark AK, Sivamani RK, Shi VY. Natural Oils for Skin-Barrier Repair: Ancient Compounds Now Backed by Modern Science. Am J Clin Dermatol. 2018 Feb; 19(1):103-117.
-
Schenck OL, Blechman AB, Kaley JR, Greer KE. Large hyperpigmented plaques on the trunk of a newborn. Cutis. 2017 Apr; 99(4):230;261;264.
-
An G, Ohls RK, Christensen RD, Widness JA, Mock DM, Veng-Pedersen P. Population Pharmacokinetics of Darbepoetin in Infants Following Single Intravenous and Subcutaneous Dosing. J Pharm Sci. 2017 06; 106(6):1644-1649.
-
Bagherani N, Smoller BR. Efficacy of topical tofacitinib, a Janus kinase inhibitor, in the treatment of plaque psoriasis. Dermatol Ther. 2017 May; 30(3).
-
Contreras MF, Raisingani M, Prasad K, Franklin B, Shah B. Transdermal testosterone gel for induction and continuation of puberty in adolescent boys with hepatic dysfunction. J Pediatr Endocrinol Metab. 2017 Jan 01; 30(1):105-109.
-
Zharov VP, Latyshev AS. Laser Non-Contact Drug Delivery Methods: Mathematical and Experimental Substantiation. Crit Rev Biomed Eng. 2017; 45(1-6):303-317.
-
Emanuelli T, Burgeiro A, Carvalho E. Effects of insulin on the skin: possible healing benefits for diabetic foot ulcers. Arch Dermatol Res. 2016 Dec; 308(10):677-694.
-
Jones SM, Agbotounou WK, Fleischer DM, Burks AW, Pesek RD, Harris MW, Martin L, Thebault C, Ruban C, Benhamou PH. Safety of epicutaneous immunotherapy for the treatment of peanut allergy: A phase 1 study using the Viaskin patch. J Allergy Clin Immunol. 2016 Apr; 137(4):1258-1261.e10.
-
Schmitz ML, Zempsky WT, Meyer JM. Safety and Efficacy of a Needle-free Powder Lidocaine Delivery System in Pediatric Patients Undergoing Venipuncture or Peripheral Venous Cannulation: Randomized Double-blind COMFORT-004 Trial. Clin Ther. 2015 Aug; 37(8):1761-72.
-
Tanghetti EA, Jackson JM, Belasco KT, Friedrichs A, Hougier F, Johnson SM, Kerdel FA, Palceski D, Hong HC, Hinek A, Cadena MJ. Optimizing the use of topical brimonidine in rosacea management: panel recommendations. J Drugs Dermatol. 2015 Jan; 14(1):33-40.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|